Bryan Burt, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Los Angeles, CANPI 1396902052
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (49.5%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 71.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $42,948 and has fallen 95.7% since, to $1,864 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $593.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$99K
- AstraZeneca$27K
- Medtronic$7K
- Fujirebio Diagnostics, Incorporated$2K
- Covidien LP$2K
- On Target Laboratories, Inc$297
- plus $779 from 7 others
Across 6 payments — averaging $7965.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$32K
- Novartis$16K
What the payments were for
- Consulting fees$16,36212%
- Speaking & faculty fees$29,16021%
- Travel & lodging$16,05512%
- Food & beverage$7,9976%
- Education$68,08249%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 151 | $98,885 |
| AstraZeneca | 31 | $27,287 |
| Medtronic | 33 | $6,509 |
| Fujirebio Diagnostics, Incorporated | 1 | $2,400 |
| Covidien LP | 3 | $1,500 |
| On Target Laboratories, Inc | 1 | $297 |
| Genentech USA, Inc. | 2 | $204 |
| Baxter Healthcare | 3 | $174 |
| Zimmer Biomet | 2 | $140 |
| Atricure, Inc. | 2 | $140 |
| Abbott | 1 | $71 |
| Johnson & Johnson | 1 | $34 |
| Galvanize Therapeutics, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$92,939
- TAGRISSO$23,453
- DA VINCI SP$4,000
- IMFINZI$3,323
- LigaSure$2,915
- Signia$2,241
- Cytalux$297
- V-LOC 180$145
- STERNALOCK BLU SYSTEM$126
- TECENTRIQ$117
How this compares
$137,656 in reported general payments places this provider in the 90th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.
See all thoracic surgery (cardiothoracic vascular surgery) providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Los Angeles
- Fernando FleischmanLos Angeles$608K
- Harmik SoukiasianLos Angeles$577K
- Jay LeeLos Angeles$462K
- Raymond LeeLos Angeles$291K
- Harold TabaieLos Angeles$120K
- Richard SheminLos Angeles$112K
- Anthony KimLos Angeles$66K
- Jonathan PraegerLos Angeles$60K
- Craig BakerLos Angeles$58K
- Thomas FogartyPortola Valley$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.